Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)

Age-related macular degeneration (AMD) is responsible for the majority of visual impairment in the Western world. The role of cholesterol-lowering medications, HMG Co-A reductase inhibitors or statins, in reducing the risk of AMD or of delaying its progression has not been fully investigated. A 3-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Guymer, Robyn H, Dimitrov, Peter N, Varsamidis, Mary, Lim, Lyndell L, Baird, Paul N, Vingrys, Algis J, Robman, Luba
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682391/
https://www.ncbi.nlm.nih.gov/pubmed/18982929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682391/
https://www.ncbi.nlm.nih.gov/pubmed/18982929

Ejemplares similares